Intriguingly, high expression of AKT1 in ccRCC is associated with better patient survival, while there is no significant association of AKT1 expression with patient survival for those with either chRCC or pRCC tumors (Fig. 16). Here, AKT1 is linked to nonpapillary renal cell carcinoma.